Tracking breast cancer recurrence after lumpectomy
Part of Cancer clinical trials.
This study tracks women who had breast-conserving surgery (lumpectomy) for breast cancer and later had a new cancer in the same breast. It aims to learn more about these recurrences and does not test a new treatment, so it may be a way to contribute to research and receive careful follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have previously had a lumpectomy (breast-conserving surgery) for breast cancer.
- After that surgery, you either had radiation therapy to the breast or did not.
- You have a recent diagnosis of new breast cancer in the same breast (either invasive or non-invasive).
- You have not had any other invasive cancer (except certain skin cancers) and have not been treated for a breast recurrence before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a “precision” approach using tumor sample testing to help predict, prevent, and treat early metastatic recurrence in triple-negative or hormone-receptor–low, HER2-negative breast cancer. If you qualify, you’ll be asked to provide tumor tissue before (or in place of) standard chemotherapy, so researchers can learn which tumor features matter most.
This study follows people who have had breast cancer come back in the same area after their first surgery. It aims to learn more about local recurrence to improve future treatment.
This trial studies a second breast-conserving surgery followed by daily radiation to just the tumor area for people whose breast cancer has returned in the same breast. It aims to see if this approach is safe and effective, potentially avoiding a mastectomy.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This study tests giving a second round of radiation therapy to women whose breast cancer has come back in the same breast, at least 3 years after their first radiation. It may be an option for women 55 and older who have a small, local recurrence that can be removed with surgery.
Hear when a new Breast Cancer Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.